Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Macrogenics (MGNX) Other Non-Current Liabilities (2016 - 2025)

Macrogenics (MGNX) has disclosed Other Non-Current Liabilities for 11 consecutive years, with $1.1 million as the latest value for Q4 2025.

  • On a quarterly basis, Other Non-Current Liabilities fell 46.54% to $1.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was $1.1 million, a 46.54% decrease, with the full-year FY2025 number at $1.1 million, down 46.54% from a year prior.
  • Other Non-Current Liabilities was $1.1 million for Q4 2025 at Macrogenics, down from $1.3 million in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $2.0 million in Q4 2024 to a low of $258000.0 in Q1 2021.
  • A 5-year average of $592700.0 and a median of $258000.0 in 2021 define the central range for Other Non-Current Liabilities.
  • Peak YoY movement for Other Non-Current Liabilities: plummeted 88.51% in 2021, then surged 662.79% in 2024.
  • Macrogenics' Other Non-Current Liabilities stood at $258000.0 in 2021, then changed by 0.0% to $258000.0 in 2022, then changed by 0.0% to $258000.0 in 2023, then soared by 662.79% to $2.0 million in 2024, then crashed by 46.54% to $1.1 million in 2025.
  • Per Business Quant, the three most recent readings for MGNX's Other Non-Current Liabilities are $1.1 million (Q4 2025), $1.3 million (Q3 2025), and $1.7 million (Q2 2025).